Yahoo
NasdaqCM - Nasdaq Real Time Price USD

PRF Technologies Ltd. (PRFX)

0.7200 -0.0001 (-0.01%)
As of 3:38:10 PM EDT. Market Open.
Chart Range Bar
Loading chart for PRFX
  • Previous Close 0.7201
  • Open 0.7161
  • Bid 0.6437 x 200
  • Ask 1.1700 x 200
  • Day's Range 0.6980 - 0.7275
  • 52 Week Range 0.6910 - 7.9500
  • Volume 52,623
  • Avg. Volume 279,470
  • Market Cap (intraday) 2.519M
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -4.0900
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

www.painreform.com

6

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More
Top Premarket Gainers

Top Premarket Gainers

Performance Overview

Trailing total returns as of 10/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PRFX
77.57%
S&P 500 (^GSPC)
11.41%

1-Year Return

PRFX
88.57%
S&P 500 (^GSPC)
13.18%

3-Year Return

PRFX
98.96%
S&P 500 (^GSPC)
80.85%

5-Year Return

PRFX
99.90%
S&P 500 (^GSPC)
67.80%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY24
Revenue --
Earnings --
Profit Margin 0.00%

Q4

FY23

Q1

FY24

Q2

FY24

Q4

FY24

-6M
-4M
-2M
0
0.0%

Statistics

View More

Valuation Measures

Annual
As of 7/10/2026
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.88%

  • Return on Equity (ttm)

    -45.33%

  • Revenue (ttm)

    31k

  • Net Income Avi to Common (ttm)

    -5.32M

  • Diluted EPS (ttm)

    -4.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.54M

  • Total Debt/Equity (mrq)

    0.30%

  • Levered Free Cash Flow (ttm)

    -2.19M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.7200 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: